Prime Medicine has yet to test prime editing in humans, but the biotech company garnered enough investor interest to boost the size of its IPO, raising $175 million. Prime claims its technology has key advantages over other gene-editing technologies and the IPO cash will support a pipeline that currently spans 18 programs.
Gilead Sciences is a leader in the field of virology treatments. As VP of clinical research for hepatitis, respiratory and emerging viruses at Gilead, Anu Osinusitalked about the pharma company's work in HIV and hepatitis and how her personal background informed her team's work in developing a Covid-19 treatment.
Surge Therapeutics' hydrogel is engineered to deliver a cancer immunotherapy. Rather than replace surgery, CEO Michael Goldberg says the hydrogel could supplement this standard of care for solid tumors. The startup's Series A financing will support the technology's first test in humans.
By Katie Adams Thursday, October 20, 2022 10:28 PM
UnityPoint Health CEO Clay Holderman said his health system made a mistake when it used to leave decision making concerning new technology adoption up to the director of its venture fund instead of involving its frontline clinicians. UnityPoint's clinicians didn't take too well to this, so the health system re-structured its technology adoption process to prioritize the voices of its clinical staff.
Price transparency data has revealed there is a high degree of price variance for healthcare procedures depending on patients' insurance carriers and the location in which services are delivered. Jaewon Ryu, Geisinger's president and CEO, said that the only way this variability can be addressed is by getting decision makers on the payment side much more aligned with the care delivery side of things.
By Jessica Ayre Thursday, October 20, 2022 11:27 AM
Texting has the power to help you build relationships, especially since it fits into most peoples' schedules, and takes almost no effort to read and respond to.
By Marissa Plescia Thursday, October 20, 2022 9:00 AM
Traditionally a wellness company focused on meditation and relaxation, Calm is moving into the healthcare space with a new solution called Calm Health. The solution will launch early next year and will cater to payers, providers and self-insured employers.
By David Greenwald Thursday, October 20, 2022 9:00 AM
Gene therapy can offer hope to patients with previously untreatable diseases, but there's more work to be done to improve both the safety and efficacy of this therapeutic modality.
Hospitals and health systems must take a comprehensive and proactive stance to protect themselves from emerging competition in telemedicine and shore up operational practices.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments